The similarities in the expression of CD105 and CD73 between PreMel and HEM, and the functional consequences that may result in diminished signaling by the TGF-β pathway for the absence of CD105, lead us to propose that CD105neg CD73low cells represent a viable alternative to replace the lost HEM in vitiligo. This evidence concerns the gene TGFB1 and vitiligo.